New software enhances CT image quality across scanner generations, supporting radiologists with improved image clarity and consistency
MENLO PARK, Calif. — June 10, 2026 — Subtle Medical, a leader in AI-powered medical imaging software, today announced FDA clearance for SubtleHD™(CT), an AI-powered image enhancement solution designed to reduce noise and improve low contrast detectability across CT imaging.
The clearance marks Subtle Medical’s first product for CT and expands the company’s AI-powered imaging portfolio across MRI, PET, and CT. It is the company’s 11th FDA-cleared product and builds on technology already deployed across more than 1,300 scanners worldwide.